|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-2-20
|
|
pubmed:abstractText |
Antiviral activity of Gefin was studied in guinea pigs infected with herpes simplex virus (HSV-2). Up to 54.9% animals challenged with HSV survived after 7-day treatment with Gefin (3 local applications a day). The prospects of further trials of the drug in HSV genital herpes are discussed.
|
|
pubmed:language |
rus
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0507-4088
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
34-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11852781-Administration, Topical,
pubmed-meshheading:11852781-Animals,
pubmed-meshheading:11852781-Antiviral Agents,
pubmed-meshheading:11852781-Disease Models, Animal,
pubmed-meshheading:11852781-Foscarnet,
pubmed-meshheading:11852781-Guinea Pigs,
pubmed-meshheading:11852781-Herpes Genitalis,
pubmed-meshheading:11852781-Herpesvirus 2, Human,
pubmed-meshheading:11852781-Male
|
|
pubmed:articleTitle |
[Therapeutic effect of gefin, a new antiviral drug, in experimental genital herpes ].
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|
